Clinical Trials Directory

Trials / Unknown

UnknownNCT06056869

Effect of Hyoscine- Bromide on Duration of the First Stage of Labor

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

Spasmolytic drugs are frequently used in delivery rooms to overcome cervical spasms and thus reduce the duration of labor. The aim of this randomized double blind placebo controlled trial is to study the efficacy of hyoscine butylbromide (HBB) for shortening of the first stage of labor in primigravid women.

Conditions

Interventions

TypeNameDescription
DRUGhyoscine butylbromidewill be given during first stage of labor intravenously
OTHERnormal salineplacebo

Timeline

Start date
2023-09-27
Primary completion
2024-04-01
Completion
2024-04-01
First posted
2023-09-28
Last updated
2023-10-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06056869. Inclusion in this directory is not an endorsement.

Effect of Hyoscine- Bromide on Duration of the First Stage of Labor (NCT06056869) · Clinical Trials Directory